CoChat

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis

Open access
Hernandez, Celine, Huebener, Peter, Pradere, Jean-Philippe, Antoine, Daniel J., Friedman, Richard A., Schwabe, Robert F. · 2018 · Journal of Clinical Investigation

The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.

Abstract

Cell death is a key driver of disease progression and carcinogenesis in chronic liver disease (CLD), highlighted by the well-established clinical correlation between hepatocellular death and risk for the development of cirrhosis and hepatocellular carcinoma (HCC). Moreover, hepatocellular death is sufficient to trigger fibrosis and HCC in mice. However, the pathways through which cell death drives CLD progression remain elusive. Here, we tested the hypothesis that high-mobility group box 1 (HMGB1), a damage-associated molecular pattern (DAMP) with key roles in acute liver injury, may link cell death to injury responses and hepatocarcinogenesis in CLD. While liver-specific HMGB1 deficiency did not significantly affect chronic injury responses such as fibrosis, regeneration, and inflammation, it inhibited ductular/progenitor cell expansion and hepatocyte metaplasia. HMGB1 promoted ductular expansion independently of active secretion in a nonautonomous fashion, consistent with its role as a DAMP. Liver-specific HMGB1 deficiency reduced HCC development in 3 mouse models of chronic injury but not in a model lacking chronic liver injury. As with CLD, HMGB1 ablation reduced the expression of progenitor and oncofetal markers, a key determinant of HCC aggressiveness, in tumors. In summary, HMGB1 links hepatocyte death to ductular reaction, progenitor signature, and hepatocarcinogenesis in CLD.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci91786

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

2 retracted

Show all 83 references

Cited by

See all 111

Metadata

Authors
Hernandez, C., Huebener, P., Pradere, J.-P., Antoine, D. J., Friedman, R. A., & Schwabe, R. F.
Affiliations
  • University Medical Center Hamburg-Eppendorf (DE)
  • Centre for Inflammation Research (GB)
  • Herbert Irving Comprehensive Cancer Center (US)
  • Columbia University (US)
Venue
Journal of Clinical Investigation
Published
2018-05-07
Volume
128
Issue
6
Pages
2436-2451
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2790482497
Cited by
110
References
85
Citations by year
2026: 3 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 22 · 2021: 13 · 2020: 15 · 2019: 19 · 2018: 5
FWCI
8.13
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Clinical Investigation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (U01AA021912)
  • National Cancer Institute (R01CA200597, P30CA013696)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116620)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
HMGB1, chronic liver disease, hepatocellular carcinoma, hepatocarcinogenesis, hepatocyte death, damage-associated molecular patterns, ductular reaction, liver progenitor cells, liver fibrosis, liver regeneration, liver inflammation
MeSH terms
Animals, Child, Preschool, Chronic Disease, Female, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Neoplasms, Male, Neoplasm Proteins, Neoplastic Stem Cells, Hepatocytes, HMGB1 Protein, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. https://app.cochat.ai/papers/10.1172/jci91786
The paper
Hernandez, C., Huebener, P., Pradere, J.-P., Antoine, D. J., Friedman, R. A., & Schwabe, R. F. (2018). HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. Journal of Clinical Investigation. https://doi.org/10.1172/jci91786

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.